Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Japanese researchers describe triazole antifungals

Feb. 7, 1997

Il Yang develops antitumor/immunostimulating proteoglycan

Feb. 7, 1997

Rockefeller University discloses antibiotic peptides

Feb. 7, 1997

Merck describes improved chemotherapeutic agents

Feb. 7, 1997

Peptide derivatives with antiinflammatory properties described by U.S. researchers

Feb. 7, 1997

Tsumura describes agents for dermatitis

Feb. 7, 1997

Chymase inhibitors from Green Cross

Feb. 7, 1997

BASF discloses antithrombotic from ticks

Feb. 6, 1997

BTG describes immunosuppressive antibodies

Feb. 6, 1997

Egis develops 5-LO inhibitors

Feb. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...